Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Staphylococcal surface proteins are a diverse group of molecules, primarily cell wall-anchored (CWA) proteins, that play a fundamental role in the pathogenesis of Staphylococcus aureus and other staphylococci (Foster et al., 2014). These proteins, often categorized as Microbial Surface Components Recognizing Adhesive Matrix Molecules (MSCRAMMs), facilitate bacterial attachment to host extracellular matrix components like fibrinogen, fibronectin, and collagen (Speziale et al., 2009). Beyond adhesion, they are instrumental in immune evasion—for instance, Protein A (Spa) binds the Fc region of antibodies to prevent opsonization—and in nutrient acquisition, such as the Isd proteins involved in heme-iron scavenging (Foster et al., 2014). Because of their essential roles in colonization and survival within the host, these proteins are primary targets for the development of vaccines and monoclonal antibodies (Speziale et al., 2009). However, the high degree of functional redundancy among different surface proteins has historically complicated the development of effective single-target therapies, leading to a shift toward multi-component strategies (Fowler et al., 2013).
Inhibition of bacterial attachment to host tissues, promotion of opsonophagocytosis by the immune system, and neutralization of immune-evasive functions such as immunoglobulin binding.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Staphylococcal surface proteins.